Asthma in adventure travelers: A prospective study evaluating the occurrence and risk factors for acute exacerbations

Archives of Internal Medicine

Volumn 162, Issue 21, 2002, Pages 2421-2426

  Golan, Yoav ^a,c   Onn, Amir ^a   Villa, Yael ^b   Avidor, Yoav ^a   Kivity, Shmuel ^a   Berger, Stephen A ^a   Shapira, Itzhak ^a   Levo, Yoram ^a   Giladi, Michael ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; GLUCOCORTICOID;

ADULT; ARTICLE; ASTHMA; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; EXERCISE TEST; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPIROMETRY; TRAVEL;

ACUTE DISEASE; ADULT; ANALYSIS OF VARIANCE; ASTHMA; BRONCHODILATOR AGENTS; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY SOUNDS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TRAVEL;

EID: 0037175502     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.21.2421     Document Type: Article

References (29)

1. Health Information for International Travel, 2001-2002. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2001.
2. International Travel and Health. Vaccination Requirements and Health Advice. Geneva, Switzerland: World Health Organization; 2000.
3. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma - United States. MMWR Morb Mortal Wkly Rep CDC Surveill Summ. 1998;47(SS-1):1-27.
4. Berger SA, Giladi M, Shapira I. Health concerns of Israelis traveling to Third World countries: Experience of a travel advisory clinic. Harefuah. 1994;126:410-412, 427.
5. Jones AP, Bentham G. Health service accessibility and deaths from asthma in 401 local authority districts in England and Wales, 1988-92. Thorax. 1997;52: 218-222.
6. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107-1136.
7. Sacher Y, Laor A, Danon YL. Longitudinal study on the prevalence of asthma among Israeli young adults. Isr J Med Sci. 1994;30:564-572.
8. Attena F, Agozzino E, Toscano G, Fedele N. Prevalence of asthma among young men in a military recruitment office of south Italy. Eur J Epidemiol. 1999;15:569-572.
9. Global initiative for asthma. Global Strategy for Asthma Management and Prevention. Bethesda, Md: National Institutes of Health; 1995. National Heart, Lung, and Blood Institute/World Health Organization Workshop Report. NIH publication 95-3659.
10. Robertson CF, Rubinfeld AR, Bowes G. Pediatric asthma deaths in Victoria: The mild are at risk. Pediatr Pulmonol. 1992;13:95-100.
11. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-fatal asthma: A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998;157:1804-1809.
12. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax. 1986;41:833-839.
13. McFadden ER Jr, Warren EL. Observations on asthma mortality. Ann Intern Med. 1997;127:142-147.
14. Campbell DA, McLennan G, Coates JR, et al. A comparison of asthma deaths and near-fatal asthma attacks in South Australia. Eur Respir J. 1994;7:490-497.
15. Richards GN, Kolbe J, Fenwick J, Rea HH. Demographic characteristics of patients with severe life-threatening asthma: Comparison with asthma deaths. Thorax. 1993;48:1105-1109.
16. Kolbe J, Fergusson W, Garrett J. Rapid onset asthma: A severe but uncommon manifestation. Thorax. 1998;53:241-247.
17. Burney PG. Asthma mortality in England and Wales: evidence for a further increase, 1974-84. Lancet. 1986;2:323-326.
18. Johnson AJ, Nunn AJ, Somner AR, Stableforth DE, Stewart CJ. Circumstances of death from asthma. BMJ. 1984;288:1870-1872.
19. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma: A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993;148:713-719.
20. Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB. Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med. 1998;157:1173-1180.
21. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near-death from asthma. N Engl J Med. 1992;326:501-506.
22. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268:3462-3464.
23. Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994;149:604-610.
24. Roghmanss MC, Sexton M. Adherence to asthma guidelines in general practices. J Asthma. 1999;36:381-387.
25. Hartert TV, Windom HH, Peebles RS Jr, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med. 1996;100:386-394.
26. Nolan P. Clinical features predictive of exercise-induced asthma in children. Respirology. 1996;1:201-205.
27. Boner AL, Vallone G, Chiesa M, Spezia E, Fambri L, Sette L. Reproducibility of late phase pulmonary response to exercise and its relationship to bronchial hyperre-activity in children with chronic asthma. Pediatr Pulmonol. 1992;14:156-159.
28. McFadden ER Jr. Exercise and asthma. N Engl J Med. 1987;317:502-504.
29. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child. 1992;67:1014-1017.